Tech Company Financing Transactions

Alzheon Funding Round

Alzheon, based in Framingham, received $10 million in funding from Ally Bridge Group and private investors.

Transaction Overview

Company Name
Announced On
4/8/2015
Transaction Type
Venture Equity
Amount
$10,000,000
Round
Series A
Investors

Ally Bridge Group (Lead Investor)

Proceeds Purpose
Proceeds of the financing will be used to advance Alzheon's lead drug candidate, ALZ-801, an oral, small molecule, first-in-class inhibitor of amyloid formation and neurotoxicity, toward completion of the clinical and regulatory studies for initiation of a potential pivotal clinical study in Alzheimer's disease in the near future.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
111 Speen St. 306
Framingham, MA 01701
USA
Email Address
Not Recorded
Overview
Alzheon, Inc., is a clinical-stage biotechnology company focused on brain health, memory and aging, developing a pipeline of innovative.
Profile
Alzheon LinkedIn Company Profile
Social Media
Alzheon Company Twitter Account
Company News
Alzheon News
Facebook
Alzheon on Facebook
YouTube
Alzheon on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Martin Tolar
  Martin Tolar LinkedIn Profile  Martin Tolar Twitter Account  Martin Tolar News  Martin Tolar on Facebook
Chief Medical Officer
Susan Abushakra
  Susan Abushakra LinkedIn Profile  Susan Abushakra Twitter Account  Susan Abushakra News  Susan Abushakra on Facebook
Chief Scientific Officer
John Hey
  John Hey LinkedIn Profile  John Hey Twitter Account  John Hey News  John Hey on Facebook
Vice President
Aidan Power
  Aidan Power LinkedIn Profile  Aidan Power Twitter Account  Aidan Power News  Aidan Power on Facebook
VP - Finance
Kenneth Mace
  Kenneth Mace LinkedIn Profile  Kenneth Mace Twitter Account  Kenneth Mace News  Kenneth Mace on Facebook


 

 

Browse more venture capital transactions:

Prev: 4/8/2015: Amberjack venture capital transaction
Next: 4/8/2015: Lens Vector venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to report on tech company VC transactions. All VC database entries on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary